Shareholders in seven of the world’s largest pharmaceutical companies have filed proposals demanding the drug companies disclose information about patents that the shareholders say pose risks to human rights, the shareholders announced.
Our Guide features ICCR member-sponsored proposals for 2026 corporate proxies along with a preliminary overview of the proxy season. Please feel free to share this resource widely with your networks. And, if you are an investor, we urge you to exercise your shareholder rights by voting your proxies.
Advancing Worker Justice Climate Change and Environmental Justice Corporate Political Accountability Digital Rights and AI Accountability Equitable Global Supply Chains Health Equity Human Rights Due Diligence Shareholder Rights and SEC Policy
Please join us on Friday, 3/20 from 11:30 am to 12:30 pm ET for a preview of ICCR members’ 2026 shareholder proposals and our 2026 Proxy Resolutions and Voting Guide. Our webinar will help contextualize the more than 400 resolutions filed by ICCR members for this proxy season, with a deeper discussion by proponents of the rationale for key initiatives. Learn about ICCR member […]
Advancing Worker Justice Climate Change and Environmental Justice Corporate Political Accountability Digital Rights and AI Accountability Health Equity Human Rights Due Diligence Shareholder Rights and SEC Policy
Request comes amid growing public alarm about corporate consolidation in the healthcare sector. New York, NY, December 2025 — A coalition of faith- and values-based investors has filed a new shareholder resolution calling on UnitedHealth Group Inc. (“UNH”) to publish a report analyzing and describing the healthcare consequences of its corporate acquisition strategy. The request […]
Equitable Access to Medicine Health Equity
Investor Statement on AI in Healthcare
Health Equity Health Equity & Technology
UnitedHealth Group’s very bad year, what it means for healthcare reform, and 3 predictors happening right now.
Equitable Access to Medicine Health Equity
As annual meetings approach, publicly traded companies navigate the inclusion of shareholder resolution proposals in their proxy materials. These companies often seek assurances from the Securities and Exchange Commission (SEC) regarding the exclusion of certain proposals, aiming to avoid potential enforcement actions.
Equitable Access to Medicine Health Equity
Publicly traded companies frequently seek guidance from the Securities and Exchange Commission (SEC) regarding the inclusion or exclusion of shareholder resolution proposals in their materials for annual meetings. This practice, while standard, has sparked debate about the potential for SEC influence on corporate decision-making and shareholder rights.
Equitable Access to Medicine Health Equity
Eden Prairie-based health care giant said one proposal missed a filing deadline, while the other was “impermissibly vague.”
Equitable Access to Medicine Health Equity
Investors cite concerns, including recent funding freezes, exits from global health bodies, and appointment of unqualified officials that may threaten equitable access to healthcare. NEW YORK, NY, THURSDAY, APRIL 17, 2025 – Members of the Interfaith Center on Corporate Responsibility today announced they had issued a public statement calling on corporations to champion policies that […]
Equitable Access to Medicine Health Equity
UnitedHealth Group is the latest company to utilise new guidance, as shareholders figure out their shifting rights.
Equitable Access to Medicine Health Equity Shareholder Rights and SEC Policy
